Skip to main content
SpringerLink
Log in

Stability-enhanced Hot-melt Extruded Amorphous Solid Dispersions via Combinations of Soluplus® and HPMCAS-HF

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The aim of this study was to evaluate a novel combination of Soluplus® and hypromellose acetate succinate (HPMCAS-HF) polymers for solubility enhancement as well as enhanced physicochemical stability of the produced amorphous solid dispersions. This was accomplished by converting the poorly water-soluble crystalline form of carbamazepine into a more soluble amorphous form within the polymeric blends. Carbamazepine (CBZ), a Biopharmaceutics Classification System class II active pharmaceutical ingredient (API) with multiple polymorphs, was utilized as a model drug. Hot-melt extrusion (HME) processing was used to prepare solid dispersions utilizing blends of polymers. Drug loading showed a significant effect on the dissolution rate of CBZ in all of the tested ratios of Soluplus® and HPMCAS-HF. CBZ was completely miscible in the polymeric blends of Soluplus® and HPMCAS-HF up to 40% drug loading. The extrudates were characterized by differential scanning calorimetry (DSC), X-ray diffraction (XRD), Fourier transform infrared (FTIR) spectroscopy and dissolution studies. DSC and XRD data confirmed the formation of amorphous solid dispersions of CBZ in the polymeric blends of Soluplus® and HPMCAS-HF. Drug loading and release of CBZ was increased with Soluplus® (when used as the primary matrix polymer) when formulations contained Soluplus® with 7–21% (w/w) HPMCAS-HF. In addition, this blend of polymers was found to be physically and chemically stable at 40°C, 75% RH over 12 months without any dissolution rate changes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10

Similar content being viewed by others

References

  1. Repka MA et al. Pharmaceutical applications of hot-melt extrusion: part II. Drug Dev Ind Pharm. 2007;33(10):1043–57.

    Article  CAS  PubMed  Google Scholar 

  2. Crowley MM et al. Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm. 2007;33(9):909–26.

    Article  CAS  PubMed  Google Scholar 

  3. Repka MA et al. Applications of hot-melt extrusion for drug delivery. 2008.

  4. Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water-soluble drugs. Drug Discov Today. 2007;12(23):1068–75.

    Article  CAS  PubMed  Google Scholar 

  5. Sotthivirat S et al. Development of amorphous solid dispersion formulations of a poorly water-soluble drug, MK-0364. Int J Pharm. 2013;452(1):73–81.

    Article  CAS  PubMed  Google Scholar 

  6. Williams RO, Watts AB, Miller DA. Formulating poorly water-soluble drugs 2012: Springer.

  7. Liu X et al. Improving the chemical stability of amorphous solid dispersion with cocrystal technique by hot melt extrusion. Pharm Res. 2012;29(3):806–17.

    Article  CAS  PubMed  Google Scholar 

  8. Li B et al. Stability and solubility enhancement of ellagic acid in cellulose ester solid dispersions. Carbohydr Polym. 2013;92(2):1443–50.

    Article  CAS  PubMed  Google Scholar 

  9. Bertilsson L, Tomson T. Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10, 11-epoxide. Clin Pharmacokinet. 1986;11(3):177–98.

    Article  CAS  PubMed  Google Scholar 

  10. Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization model list of essential medicines according to the Biopharmaceutics Classification System. Eur J Pharm Biopharm. 2004;58(2):265–78.

    Article  PubMed  Google Scholar 

  11. Moneghini M et al. Study of the solid state of carbamazepine after processing with gas anti-solvent technique. Eur J Pharm Biopharm. 2003;56(2):281–9.

    Article  CAS  PubMed  Google Scholar 

  12. Hickey MB et al. Performance comparison of a co-crystal of carbamazepine with marketed product. Eur J Pharm Biopharm. 2007;67(1):112–9.

    Article  CAS  PubMed  Google Scholar 

  13. Grzesiak AL et al. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. J Pharm Sci. 2003;92(11):2260–71.

    Article  CAS  PubMed  Google Scholar 

  14. Hardung H, Djuric D, Ali S. Combining HME & solubilization: Soluplus®—the solid solution. Drug Deliv Technol. 2010;10(3):20–7.

    CAS  Google Scholar 

  15. Liu H et al. Effects of extrusion process parameters on the dissolution behavior of indomethacin in Eudragit® E PO solid dispersions. Int J Pharm. 2010;383(1):161–9.

    Article  CAS  PubMed  Google Scholar 

  16. Prodduturi S et al. Stabilization of hot-melt extrusion formulations containing solid solutions using polymer blends. AAPS PharmSciTech. 2007;8(2):E152–61.

    Article  PubMed Central  Google Scholar 

  17. Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci. 1997;86(1):1–12.

    Article  CAS  PubMed  Google Scholar 

  18. Li B et al. Both solubility and chemical stability of curcumin are enhanced by solid dispersion in cellulose derivative matrices. Carbohydr Polym. 2013;98(1):1108–16.

    Article  CAS  PubMed  Google Scholar 

  19. Al-Obaidi H, Buckton G. Evaluation of griseofulvin binary and ternary solid dispersions with HPMCAS. AAPS PharmSciTech. 2009;10(4):1172–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. FDA U. Guidance for industry waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a Biopharmaceutics Classification System. Food and Drug Administration, Center for Drug Evaluation and Research (CDER) 2000.

  21. Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm. 2004;272(1):1–10.

    Article  CAS  PubMed  Google Scholar 

  22. Krahn FU, Mielck JB. Effect of type and extent of crystalline order on chemical and physical stability of carbamazepine. Int J Pharm. 1989;53(1):25–34.

    Article  CAS  Google Scholar 

  23. Djuris J et al. Preparation of carbamazepine–Soluplus® solid dispersions by hot-melt extrusion, and prediction of drug–polymer miscibility by thermodynamic model fitting. Eur J Pharm Biopharm. 2013;84(1):228–37.

    Article  CAS  PubMed  Google Scholar 

  24. Tanno F et al. Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions. Drug Dev Ind Pharm. 2004;30(1):9–17.

    Article  CAS  PubMed  Google Scholar 

  25. Rumondor AC, Stanford LA, Taylor LS. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions. Pharm Res. 2009;26(12):2599–606.

    Article  CAS  PubMed  Google Scholar 

  26. Ueda K et al. Inhibitory effect of hydroxypropyl methylcellulose acetate succinate on drug recrystallization from a supersaturated solution assessed using nuclear magnetic resonance measurements. Mol Pharm. 2013;10(10):3801–11.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This project was supported and funded by Grant Numbers P20GM104932 from the National Institute of General Medical Sciences (NIGMS), a component of NIH for contributions to this project. The authors also thank the Pii Center for Pharmaceutical Technology for contributions to this project.

Author information

Authors and Affiliations

  1. Department of Pharmaceutics and Drug Delivery, School of Pharmacy, The University of Mississippi, University, Mississippi, 38677, USA

    Saad M. Alshahrani, Wenli Lu, Jun-Bom Park, Joseph T. Morott, Bader B. Alsulays, Soumyajit Majumdar & Michael A. Repka

  2. BASF Corporation, 500 White Plains Road, Tarrytown, New York, 10591, USA

    Nigel Langley

  3. BASF SE, R&D Project, Management Excipients, Ludwigshafen, 67056, Germany

    Karl Kolter

  4. BASF SE, Global Development and Technical Marketing, Ludwigshafen, 67056, Germany

    Andreas Gryczke

  5. Pii Center for Pharmaceutical Technology, The University of Mississippi, University, Mississippi, 38677, USA

    Michael A. Repka

Authors
  1. Saad M. Alshahrani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wenli Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jun-Bom Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joseph T. Morott
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bader B. Alsulays
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Soumyajit Majumdar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nigel Langley
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Karl Kolter
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Andreas Gryczke
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Michael A. Repka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael A. Repka.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alshahrani, S.M., Lu, W., Park, JB. et al. Stability-enhanced Hot-melt Extruded Amorphous Solid Dispersions via Combinations of Soluplus® and HPMCAS-HF. AAPS PharmSciTech 16, 824–834 (2015). https://doi.org/10.1208/s12249-014-0269-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-014-0269-6

KEY WORDS

Search

Navigation